|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to authorizing the possession, use, cultivation, |
|
distribution, delivery, sale, and research of medical cannabis for |
|
medical use by patients with certain medical conditions and the |
|
licensing of medical cannabis organizations; authorizing a fee. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
ARTICLE 1. CHANGES TO TEXAS COMPASSIONATE USE PROGRAM |
|
SECTION 1.01. Section 487.001, Health and Safety Code, is |
|
amended to read as follows: |
|
Sec. 487.001. DEFINITIONS. In this chapter: |
|
(1) "Caregiver" means a person who has a significant |
|
responsibility for managing the well-being of a registered patient. |
|
A caregiver may be either an individual or an organization or other |
|
entity, including a long-term care facility, other health care |
|
organization, or public institution. |
|
(2) "Department" means the Department of Public |
|
Safety. |
|
(3) [(2)] "Director" means the public safety director |
|
of the department. |
|
[(3) "Dispensing organization" means an organization |
|
licensed by the department to cultivate, process, and dispense |
|
low-THC cannabis to a patient for whom low-THC cannabis is |
|
prescribed under Chapter 169, Occupations Code.] |
|
(4) "Medical [Low-THC] cannabis" has the meaning |
|
assigned by Section 169.001, Occupations Code. |
|
(5) "Medical cannabis organization" means any |
|
organization that cultivates, processes, manufactures, |
|
distributes, researches, tests, dispenses, or conducts other |
|
business regarding medical cannabis as authorized by a license |
|
issued by the department under this chapter. |
|
(6) "Medical cannabis product" means a product, other |
|
than cannabis itself, which contains or is derived from cannabis. |
|
The term does not include a product derived from hemp, as defined by |
|
Section 121.001, Agriculture Code, or a consumable hemp product, as |
|
defined by Section 443.001 of this code. |
|
(7) "Medical use" has the meaning assigned by Section |
|
169.001, Occupations Code. |
|
SECTION 1.02. Subchapter A, Chapter 487, Health and Safety |
|
Code, is amended by adding Section 487.002 to read as follows: |
|
Sec. 487.002. ALLOWABLE AMOUNT OF MEDICAL CANNABIS. The |
|
allowable amount of medical cannabis for a person for whom medical |
|
use is recommended under Chapter 169, Occupations Code, is an |
|
amount of cannabis in any form approved by the physician possessed |
|
by a qualified patient or collectively possessed by a qualified |
|
patient and the qualified patient's caregiver that is: |
|
(1) not more than reasonably necessary to ensure the |
|
uninterrupted availability of cannabis for a period of three months |
|
based on the individual patient's recommended amount of medical |
|
cannabis; and |
|
(2) obtained solely from a medical cannabis |
|
organization. |
|
SECTION 1.03. Chapter 487, Health and Safety Code, is |
|
amended by adding Subchapter A-1 to read as follows: |
|
SUBCHAPTER A-1. PROTECTIONS RELATED TO MEDICAL USE OF CANNABIS |
|
Sec. 487.021. PROTECTION FROM LEGAL ACTION. (a) This |
|
section applies to a person who is: |
|
(1) a patient for whom medical use is recommended |
|
under Chapter 169, Occupations Code, or the parent, legal guardian, |
|
or caregiver of a patient; |
|
(2) a medical cannabis organization; |
|
(3) a director, manager, or employee of a medical |
|
cannabis organization who is registered with the department under |
|
Section 487.053; or |
|
(4) a person participating as a researcher or patient |
|
in an approved research program under Subchapter G, Chapter 481. |
|
(b) Notwithstanding any other law, a person described by |
|
Subsection (a) is not subject to arrest, prosecution, or penalty in |
|
any manner, or denial of any right or privilege, including any civil |
|
penalty or disciplinary action by a court or occupational or |
|
professional licensing board or bureau, for conduct involving |
|
medical use that is authorized under this chapter, Subchapter G, |
|
Chapter 481, of this code, Chapter 169, Occupations Code, or |
|
department rule. |
|
Sec. 487.022. NO PRESUMPTION OF CHILD ABUSE, NEGLECT, OR |
|
ENDANGERMENT. A person described by Section 487.021(a) may not be |
|
presumed to have engaged in conduct constituting child abuse, |
|
neglect, or endangerment solely because the person engaged in |
|
conduct involving medical use that is authorized under this |
|
chapter, Subchapter G, Chapter 481, of this code, Chapter 169, |
|
Occupations Code, or department rule. |
|
Sec. 487.023. NO DENIAL OF PARENTAL RIGHTS. The fact that a |
|
person described by Section 487.021(a) engages in conduct |
|
authorized under this chapter, Subchapter G, Chapter 481, of this |
|
code, Chapter 169, Occupations Code, or department rule, does not |
|
in itself constitute grounds for denying, limiting, or restricting |
|
conservatorship or possession of or access to a child under Title 5, |
|
Family Code. |
|
Sec. 487.024. NO SEIZURE OR FORFEITURE. Property used in |
|
the cultivation, research, testing, processing, distribution, |
|
transportation, and delivery of medical cannabis for medical use |
|
that is authorized under this chapter, Subchapter G, Chapter 481, |
|
of this code, Chapter 169, Occupations Code, or department rule, is |
|
not contraband for purposes of Chapter 59, Code of Criminal |
|
Procedure, and is not subject to seizure or forfeiture under that |
|
chapter or other law solely for the use of the property in those |
|
authorized activities. |
|
Sec. 487.025. NO PROSECUTION FOR PROVISION OF |
|
PARAPHERNALIA. A person is not subject to arrest, prosecution, or |
|
the imposition of any sentence or penalty for the delivery, |
|
possession with intent to deliver, or manufacture of any item that |
|
meets the definition of drug paraphernalia, as defined by Section |
|
481.002, if that item is delivered, possessed with intent to |
|
deliver, or manufactured for the sole purpose of providing that |
|
item to: |
|
(1) a patient for whom medical use is recommended |
|
under Chapter 169, Occupations Code, or the parent, legal guardian, |
|
or caregiver of a patient; |
|
(2) a medical cannabis organization; |
|
(3) a director, manager, or employee of a medical |
|
cannabis organization who is registered with the department under |
|
Section 487.053; or |
|
(4) a person participating as a researcher or patient |
|
in an approved research program under Subchapter G, Chapter 481. |
|
Sec. 487.026. NO PUNISHMENT FOR STUDENT PATIENTS AND THEIR |
|
CAREGIVERS. Notwithstanding any other law: |
|
(1) a student enrolled in any school, junior college, |
|
college, university, or other educational institution for whom |
|
medical cannabis was recommended under Chapter 169, Occupations |
|
Code, may not be subject to suspension, expulsion, placement in a |
|
disciplinary alternative education program, or any other form of |
|
discipline solely because the student possessed, used, or received |
|
a valid recommendation for medical cannabis; and |
|
(2) a health care professional providing services at |
|
any school, junior college, college, university, or other |
|
educational institution may not be subject to any discipline solely |
|
for assisting a student in the administration of medical cannabis. |
|
SECTION 1.04. Section 487.052, Health and Safety Code, is |
|
amended to read as follows: |
|
Sec. 487.052. RULES; FEES. (a) The director shall adopt |
|
any rules necessary for the administration and enforcement of this |
|
chapter. |
|
(b) The director shall adopt [, including] rules imposing |
|
reasonable fees under this chapter in amounts sufficient to cover |
|
the cost of administering this chapter. The department shall also |
|
use revenue from fees to establish a cannabis testing and quality |
|
control fund for the purpose of assisting law enforcement, |
|
including accredited crime laboratories, to purchase instruments, |
|
establish methods, and obtain resources needed to conduct forensic |
|
analysis necessary to enforce this subtitle and to protect the |
|
health and safety of medical cannabis patients and the public. |
|
(c) The fees adopted under Subsection (b) may not exceed: |
|
(1) $5,000 for application fees; |
|
(2) $100 for registration fees under Subchapter D; and |
|
(3) reasonable amounts for the issuance or renewal of |
|
each class of license. |
|
(d) The director may not adopt rules establishing a total |
|
limit on the number of medical cannabis organization licenses by |
|
class that may be granted nor set the price of or production |
|
quantity of medical cannabis. |
|
SECTION 1.05. Subchapter B, Chapter 487, Health and Safety |
|
Code, is amended by adding Sections 487.0521 and 487.0522 to read as |
|
follows: |
|
Sec. 487.0521. SAFETY. (a) The director by rule shall |
|
adopt packaging and labeling requirements for medical cannabis to |
|
ensure patients are informed and protected. In adopting packaging |
|
and labeling requirements, the director shall ensure that: |
|
(1) each medical cannabis package is labeled with the |
|
cannabinoid potency and terpenes profile of medical cannabis or |
|
medical cannabis product as determined by an independent testing |
|
laboratory; |
|
(2) each medical cannabis product and medical cannabis |
|
package is labeled with the required warnings as determined by the |
|
department; and |
|
(3) the packaging and label of medical cannabis or a |
|
medical cannabis product: |
|
(A) do not contain any false or misleading |
|
statements; and |
|
(B) are not designed to appeal to children. |
|
(b) The director shall adopt necessary rules to allow the |
|
department to monitor the safety and efficacy of medical cannabis |
|
or medical cannabis products, including rules: |
|
(1) requiring accurate reporting to consumers |
|
regarding the content of medical cannabis or medical cannabis |
|
products; |
|
(2) providing for random testing by the department or |
|
the department's designee to ensure compliance with labeling and |
|
reporting requirements; and |
|
(3) providing for health and safety regulations and |
|
standards for the manufacture and cultivation of medical cannabis |
|
and medical cannabis products. |
|
(c) The director may collect data from medical cannabis |
|
organizations and health care providers as necessary to enable the |
|
department to monitor the safety and efficacy of medical cannabis. |
|
The director may adopt rules for the data collection under this |
|
subsection. |
|
Sec. 487.0522. MEDICAL CANNABIS INVENTORY SYSTEM. (a) The |
|
department shall establish and maintain a medical cannabis |
|
inventory system that oversees the tracking, tracing, testing, and |
|
quality control and quality assurance certification of medical |
|
cannabis and medical cannabis products. |
|
(b) The department may contract with other entities to |
|
establish and maintain all or part of the medical cannabis |
|
inventory system on behalf of the department. |
|
(c) A medical cannabis organization shall use the medical |
|
cannabis inventory system approved by the department to keep |
|
records throughout the cannabis supply chain, including for every |
|
transaction between license holders and between license holders and |
|
patients. A medical cannabis organization may additionally use its |
|
own system for keeping records under this chapter provided the |
|
organization's system can integrate with the department's medical |
|
cannabis inventory system as required under this chapter and rules |
|
adopted under this chapter. |
|
(d) The records in the medical cannabis inventory system |
|
must include for each transaction: |
|
(1) the name, license number, and assigned |
|
identification number of the license holder that cultivated, |
|
manufactured, tested, or sold the product; |
|
(2) the address and phone number of the license holder |
|
that cultivated, manufactured, tested, or sold the product; |
|
(3) the type and weight of medical cannabis or medical |
|
cannabis product transferred or received during the transaction; |
|
(4) the batch number of the medical cannabis or |
|
medical cannabis product used; |
|
(5) the date of the transaction; |
|
(6) the total spent in dollars; and |
|
(7) any additional information the department |
|
requires. |
|
(e) The records in the medical cannabis inventory system |
|
must include for each license holder: |
|
(1) the amount of any medical cannabis waste, in |
|
pounds; |
|
(2) all point-of-sale records; and |
|
(3) any additional information the department |
|
requires. |
|
(f) Notwithstanding Subsection (c), before the department |
|
establishes the medical cannabis inventory system described by that |
|
subsection, each license holder shall use its own inventory system |
|
that meets the requirements of this section. |
|
(g) Each medical cannabis organization has a continuing |
|
responsibility to maintain records on site that are readily |
|
available to the department regardless of the functionality of the |
|
medical cannabis inventory system, including the criteria |
|
established by this section and any requirements established by |
|
rule. |
|
(h) The director shall adopt rules necessary for the |
|
implementation and enforcement of this section, including rules |
|
ensuring: |
|
(1) the department has 24-hour access to the medical |
|
cannabis inventory system; and |
|
(2) all inventory records containing patient |
|
information comply with Chapter 181 and the Health Insurance |
|
Portability and Accountability Act of 1996 (42 U.S.C. Section 1320d |
|
et seq.). |
|
SECTION 1.06. The heading to Section 487.053, Health and |
|
Safety Code, is amended to read as follows: |
|
Sec. 487.053. LICENSING OF MEDICAL CANNABIS [DISPENSING] |
|
ORGANIZATIONS AND REGISTRATION OF CERTAIN ASSOCIATED INDIVIDUALS. |
|
SECTION 1.07. Section 487.053(a), Health and Safety Code, |
|
is amended to read as follows: |
|
(a) The department shall: |
|
(1) issue or renew a license under Subchapter C to |
|
operate as a medical cannabis [dispensing] organization to each |
|
applicant who satisfies the requirements established under this |
|
chapter for licensure under that class of medical cannabis |
|
organization; [and] |
|
(2) register directors, managers, and employees under |
|
Subchapter D of each medical cannabis [dispensing] organization; |
|
(3) issue a permit for an additional location to a |
|
dispensing cannabis organization license holder on application if |
|
the license holder is in compliance with all eligibility |
|
requirements and the proposed location complies with any local |
|
zoning requirements and will assist with ensuring reasonable |
|
statewide access; |
|
(4) to ensure reasonable statewide access, issue not |
|
fewer than the following number of licenses or permits, as |
|
applicable, for each type of medical cannabis organization provided |
|
the department receives an adequate number of qualified |
|
applications: |
|
(A) dispensing cannabis organization licenses or |
|
permits for an additional location for a dispensing cannabis |
|
organization license holder, as applicable, based on population |
|
within each of the 11 public health regions established by the |
|
Health and Human Services Commission, as follows: |
|
(i) 9 in public health region 1; |
|
(ii) 6 in public health region 2; |
|
(iii) 82 in public health region 3; |
|
(iv) 12 in public health region 4; |
|
(v) 8 in public health region 5; |
|
(vi) 75 in public health region 6; |
|
(vii) 37 in public health region 7; |
|
(viii) 31 in public health region 8; |
|
(ix) 7 in public health region 9; |
|
(x) 9 in public health region 10; and |
|
(xi) 24 in public health region 11; |
|
(B) one cultivation cannabis organization |
|
license for every four dispensing cannabis organization licenses; |
|
(C) one processing cannabis organization license |
|
for every three dispensing cannabis organization licenses; and |
|
(D) the number of independent testing cannabis |
|
organization licenses necessary to meet demand; |
|
(5) when the number of registered medical cannabis |
|
patients reaches 100,000, issue not fewer than 24 additional |
|
dispensing cannabis organization licenses or location permits, as |
|
applicable, and the appropriate number of other medical cannabis |
|
organization license types as prescribed by Subdivision (4); and |
|
(6) for each additional 100,000 registered medical |
|
cannabis patients beyond the first 100,000 patients described by |
|
Subdivision (5), issue not fewer than 24 additional dispensing |
|
cannabis organization licenses or location permits, as applicable, |
|
and the appropriate number of other medical cannabis organization |
|
license types as prescribed by Subdivision (4). |
|
SECTION 1.08. Section 487.054, Health and Safety Code, is |
|
amended to read as follows: |
|
Sec. 487.054. COMPASSIONATE-USE REGISTRY. (a) The |
|
department shall establish and maintain a secure online |
|
compassionate-use registry that contains: |
|
(1) the name of each physician who registers as a |
|
physician recommending medical cannabis and for each patient for |
|
whom the physician has registered: |
|
(A) [the prescriber for a patient under Section |
|
169.004, Occupations Code,] the patient's name, and any caregivers' |
|
names, if applicable; |
|
(B) the patient's [and] date of birth; |
|
(C) the nature of the patient's eligible medical |
|
condition; |
|
(D) [of the patient,] the dosage recommended; |
|
(E) [prescribed,] the means of administration |
|
ordered; [,] and |
|
(F) the total amount of medical [low-THC] |
|
cannabis required to fill the patient's recommendation |
|
[prescription]; and |
|
(2) a record of each amount of medical [low-THC] |
|
cannabis dispensed by a medical cannabis [dispensing] organization |
|
to a patient under a recommendation [prescription]. |
|
(b) The department shall ensure the registry: |
|
(1) is designed to prevent more than one qualified |
|
physician from registering as the recommending physician |
|
[prescriber] for a single patient; |
|
(2) is accessible to law enforcement agencies and |
|
medical cannabis [dispensing] organizations licensed to dispense |
|
medical cannabis for the purpose of verifying whether a patient is |
|
one for whom medical [low-THC] cannabis is recommended [prescribed] |
|
and whether the patient's recommendations [prescriptions] have |
|
been filled; [and] |
|
(3) allows a physician [qualified to prescribe low-THC |
|
cannabis under Section 169.002, Occupations Code,] to input safety |
|
and efficacy data derived from the treatment of patients for whom |
|
medical [low-THC] cannabis is recommended [prescribed] under |
|
Chapter 169, Occupations Code, including any severe adverse effects |
|
due to the medical use of medical cannabis; and |
|
(4) ensures that all application records and |
|
information are sealed to protect the privacy of patients. |
|
(c) The handling of any records maintained in the registry |
|
must comply with all relevant state and federal privacy laws, |
|
including Chapter 181. |
|
SECTION 1.09. Subchapter B, Chapter 487, Health and Safety |
|
Code, is amended by adding Section 487.055 to read as follows: |
|
Sec. 487.055. DESIGNATION OF CAREGIVER. (a) A patient |
|
listed in the compassionate-use registry may designate a caregiver. |
|
A caregiver designated under this subsection may be either an |
|
individual or an organization or other entity, including a |
|
long-term care facility, other health care organization, or public |
|
institution. |
|
(b) The department shall develop a form for a patient listed |
|
in the registry to designate a caregiver under Subsection (a). The |
|
form must require the patient to provide the full name, home |
|
address, and date of birth of the patient's caregiver or, in the |
|
case of a caregiver that is an entity, the entity's name and |
|
address. |
|
(c) A caregiver may possess medical cannabis and medical |
|
cannabis products up to the sum of the possession limits for all |
|
patients under the caregiver's care. |
|
(d) The director shall adopt rules necessary to implement |
|
this section, including rules to provide identification cards for |
|
designated caregivers. |
|
SECTION 1.10. The heading to Subchapter C, Chapter 487, |
|
Health and Safety Code, is amended to read as follows: |
|
SUBCHAPTER C. LICENSE TO OPERATE AS MEDICAL CANNABIS [DISPENSING] |
|
ORGANIZATION |
|
SECTION 1.11. Section 487.101, Health and Safety Code, is |
|
amended to read as follows: |
|
Sec. 487.101. LICENSE REQUIRED. (a) A license issued by |
|
the department under this chapter is required to operate a medical |
|
cannabis [dispensing] organization. |
|
(b) The director by rule shall adopt application and |
|
licensing requirements and privileges of each medical cannabis |
|
organization license type. |
|
(c) Medical cannabis organization license types shall |
|
include the following: |
|
(1) a cultivating cannabis organization that |
|
cultivates medical cannabis for sale and distribution to other |
|
medical cannabis organizations and may process and package medical |
|
cannabis for individual sale so long as the cannabis is not |
|
subjected to any chemical alteration; |
|
(2) a processing cannabis organization that extracts |
|
medical cannabis and manufactures, prepares, and packages medical |
|
cannabis products for sale and distribution to other medical |
|
cannabis organizations; |
|
(3) a dispensing cannabis organization that sells |
|
medical cannabis and medical cannabis products to patients; |
|
(4) an independent testing cannabis organization that |
|
tests medical cannabis and medical cannabis products for potency, |
|
safety, and efficacy; and |
|
(5) any other class of medical cannabis organization |
|
that the department finds warranted to safely and securely ensure |
|
reasonable statewide access of medical cannabis for medical use. |
|
SECTION 1.12. Section 487.102, Health and Safety Code, is |
|
amended to read as follows: |
|
Sec. 487.102. ELIGIBILITY FOR LICENSE. An applicant for a |
|
license to operate as a medical cannabis [dispensing] organization |
|
is eligible for the license if: |
|
(1) as determined by the department, the applicant |
|
possesses: |
|
(A) the technical and technological ability |
|
appropriate for that class of license [to cultivate and produce |
|
low-THC cannabis]; |
|
(B) the ability to secure: |
|
(i) the resources and personnel necessary |
|
to operate as a medical cannabis [dispensing] organization; and |
|
(ii) for distribution or |
|
dispensing premises reasonably located to allow patients listed on |
|
the compassionate-use registry access to the organization through |
|
existing infrastructure; |
|
(C) the ability to maintain accountability for |
|
the raw materials, the finished product, and any by-products used |
|
or produced in the cultivation or production of medical [low-THC] |
|
cannabis to prevent unlawful access to or unlawful diversion or |
|
possession of those materials, products, or by-products; [and] |
|
(D) the financial ability to maintain operations |
|
for not less than two years from the date of application; and |
|
(E) any specific qualifications for licensure |
|
for each class of license the department requires by rule under this |
|
chapter that are demonstrably related to the operations authorized |
|
and duties imposed under that class of license to safely and |
|
securely provide medical cannabis for medical use to patients; |
|
(2) each director, manager, or employee of the |
|
applicant is registered under Subchapter D; and |
|
(3) the applicant satisfies any additional criteria |
|
determined by the director to be necessary to safely implement this |
|
chapter. |
|
SECTION 1.13. Subchapter C, Chapter 487, Health and Safety |
|
Code, is amended by adding Section 487.1021 to read as follows: |
|
Sec. 487.1021. ELIGIBILITY FOR LICENSE TO OPERATE AS AN |
|
INDEPENDENT CANNABIS TESTING ORGANIZATION. In addition to the |
|
criteria described by Section 487.102, an applicant for a license |
|
to operate as an independent cannabis testing organization is |
|
eligible for the license if the applicant: |
|
(1) submits proof of accreditation by an independent |
|
accreditation body in accordance with the International |
|
Organization for Standardization ISO/IEC 17025 or a comparable or |
|
successor standard designated by department rule; |
|
(2) submits proof that it does not share ownership |
|
interest or joint management with any medical cannabis organization |
|
whose product the applicant may test except for less than 10 percent |
|
ownership in a publicly traded company; and |
|
(3) satisfies any additional criteria determined by |
|
the department to be necessary for the operation of a cannabis |
|
testing facility. |
|
SECTION 1.14. Section 487.103(a), Health and Safety Code, |
|
is amended to read as follows: |
|
(a) A person may apply for an initial or renewal license to |
|
operate as a medical cannabis [dispensing] organization by |
|
submitting a form prescribed by the department along with the |
|
application fee in an amount set by the director for that class of |
|
license. |
|
SECTION 1.15. Section 487.104(a), Health and Safety Code, |
|
is amended to read as follows: |
|
(a) The department shall issue or renew a license to operate |
|
as a medical cannabis [dispensing] organization [only] if: |
|
(1) the department determines the applicant meets the |
|
eligibility requirements described by Section 487.102 or 487.1021, |
|
as applicable; and |
|
(2) issuance or renewal of the license would assist |
|
[is necessary to ensure] reasonable statewide access to, and the |
|
availability of, medical [low-THC] cannabis for patients |
|
registered in the compassionate-use registry and for whom medical |
|
[low-THC] cannabis is recommended [prescribed] under Chapter 169, |
|
Occupations Code. |
|
SECTION 1.16. Sections 487.105(a) and (b), Health and |
|
Safety Code, are amended to read as follows: |
|
(a) An applicant for the issuance or renewal of a license |
|
under this subchapter [to operate as a dispensing organization] |
|
shall provide the department with the applicant's name and the name |
|
of each of the applicant's directors, managers, and employees. |
|
(b) Before a medical cannabis [dispensing] organization |
|
license holder [licensee] hires a manager or employee for the |
|
organization, the license holder [licensee] must provide the |
|
department with the name of the prospective manager or employee. |
|
The license holder [licensee] may not transfer the license to |
|
another person before that prospective applicant and the |
|
applicant's directors, managers, and employees pass a criminal |
|
history background check and any other requirements established by |
|
the director by rule, and are registered as required by Subchapter |
|
D. |
|
SECTION 1.17. Section 487.106, Health and Safety Code, is |
|
amended to read as follows: |
|
Sec. 487.106. DUTY TO MAINTAIN ELIGIBILITY. (a) Each |
|
license holder under this subchapter [A dispensing organization] |
|
must maintain compliance at all times with the eligibility |
|
requirements described by Section 487.102 or 487.1021, as |
|
applicable. |
|
(b) On request of the department, a license holder must |
|
provide to the department a reasonably sized sample suitable for |
|
testing of medical cannabis. |
|
SECTION 1.18. Section 487.107, Health and Safety Code, is |
|
amended to read as follows: |
|
Sec. 487.107. DUTIES RELATING TO DISPENSING MEDICAL |
|
CANNABIS [PRESCRIPTION]. (a) Before dispensing medical [low-THC] |
|
cannabis to a person for whom the medical [low-THC] cannabis is |
|
recommended [prescribed] under Chapter 169, Occupations Code, the |
|
medical cannabis [dispensing] organization must verify that the |
|
recommendation [prescription] presented: |
|
(1) is for a person listed as a patient in the |
|
compassionate-use registry; |
|
(2) matches the entry in the compassionate-use |
|
registry with respect to the total amount of medical [low-THC] |
|
cannabis required to fill the recommendation [prescription]; and |
|
(3) has not previously been filled by a medical |
|
cannabis [dispensing] organization as indicated by an entry in the |
|
compassionate-use registry. |
|
(b) After dispensing medical [low-THC] cannabis to a |
|
patient for whom the medical [low-THC] cannabis is recommended |
|
[prescribed] under Chapter 169, Occupations Code, the medical |
|
cannabis [dispensing] organization shall record in the |
|
compassionate-use registry the form and quantity of medical |
|
[low-THC] cannabis dispensed and the date and time of dispensation. |
|
SECTION 1.19. Sections 487.108(a), (b), and (c), Health and |
|
Safety Code, are amended to read as follows: |
|
(a) The department may at any time suspend or revoke a |
|
license issued under this subchapter [chapter] if the department |
|
determines that the license holder [licensee] has not maintained |
|
the eligibility requirements described by Section 487.102 or |
|
487.1021, as applicable, or has failed to comply with a duty imposed |
|
under this chapter. |
|
(b) The director shall give written notice to the license |
|
holder [dispensing organization] of a license suspension or |
|
revocation under this section and the grounds for the suspension or |
|
revocation. The notice must be sent by certified mail, return |
|
receipt requested. |
|
(c) After suspending or revoking a license issued under this |
|
subchapter [chapter], the director may seize or place under seal |
|
all medical [low-THC] cannabis and drug paraphernalia owned or |
|
possessed by the license holder [dispensing organization]. If the |
|
director orders the revocation of the license, a disposition may |
|
not be made of the seized or sealed medical [low-THC] cannabis or |
|
drug paraphernalia until the time for administrative appeal of the |
|
order has elapsed or until all appeals have been concluded. When a |
|
revocation order becomes final, all medical [low-THC] cannabis and |
|
drug paraphernalia may be forfeited to the state as provided under |
|
Subchapter E, Chapter 481. |
|
SECTION 1.20. Section 487.151(a), Health and Safety Code, |
|
is amended to read as follows: |
|
(a) An individual who is a director, manager, or employee of |
|
a license holder under Subchapter C [dispensing organization] must |
|
apply for and obtain a registration under this section. |
|
SECTION 1.21. Section 487.201, Health and Safety Code, is |
|
amended to read as follows: |
|
Sec. 487.201. COUNTIES AND MUNICIPALITIES MAY NOT PROHIBIT |
|
MEDICAL [LOW-THC] CANNABIS. A municipality, county, or other |
|
political subdivision may not enact, adopt, or enforce a rule, |
|
ordinance, order, resolution, or other regulation that prohibits |
|
the cultivation, production, dispensing, researching, testing, or |
|
possession of medical [low-THC] cannabis, as authorized by this |
|
chapter. |
|
SECTION 1.22. Subchapter F, Chapter 487, Health and Safety |
|
Code, is repealed. |
|
ARTICLE 2. RECOMMENDATION OF MEDICAL CANNABIS BY PHYSICIAN |
|
SECTION 2.01. The heading to Chapter 169, Occupations Code, |
|
is amended to read as follows: |
|
CHAPTER 169. AUTHORITY TO RECOMMEND MEDICAL [PRESCRIBE LOW-THC] |
|
CANNABIS TO CERTAIN PATIENTS FOR COMPASSIONATE USE |
|
SECTION 2.02. Section 169.001, Occupations Code, is amended |
|
to read as follows: |
|
Sec. 169.001. DEFINITIONS. In this chapter: |
|
(1) "Department" means the Department of Public |
|
Safety. |
|
(2) [(1-a) "Incurable neurodegenerative disease" |
|
means a disease designated as an incurable neurodegenerative |
|
disease by rule of the executive commissioner of the Health and |
|
Human Services Commission, adopted in consultation with the |
|
National Institutes of Health. |
|
[(3)] "Medical [Low-THC] cannabis" means the plant |
|
Cannabis sativa L., and any part of that plant or any compound, |
|
manufacture, salt, derivative, mixture, preparation, resin, or oil |
|
of that plant. The term does not include hemp, as defined by |
|
Section 121.001, Agriculture Code, or a consumable hemp product, as |
|
defined by Section 443.001, Health and Safety Code [that contains |
|
not more than one percent by weight of tetrahydrocannabinols]. |
|
(3) [(4)] "Medical use" means the administration of |
|
medical cannabis to a registered patient for treatment of an |
|
eligible medical condition or symptoms as recommended by a |
|
physician [ingestion by a means of administration other than by |
|
smoking of a prescribed amount of low-THC cannabis by a person for |
|
whom low-THC cannabis is prescribed] under this chapter. |
|
(4) "Severe adverse event" means an adverse event |
|
that: |
|
(A) results in death; |
|
(B) results in an illness requiring |
|
hospitalization; |
|
(C) is considered life-threatening; or |
|
(D) results in a persistent or significant |
|
disability, incapacity, or medically important condition. |
|
[(5) "Smoking" means burning or igniting a substance |
|
and inhaling the smoke.] |
|
SECTION 2.03. Chapter 169, Occupations Code, is amended by |
|
adding Section 169.0012 to read as follows: |
|
Sec. 169.0012. BONA FIDE PHYSICIAN-PATIENT RELATIONSHIP. |
|
For purposes of this chapter, a bona fide physician-patient |
|
relationship exists when there is a treatment or counseling |
|
relationship between a physician and patient in which all of the |
|
following are present: |
|
(1) the physician has reviewed the patient's relevant |
|
medical records and completed a full assessment of the patient's |
|
medical history and current medical condition, including a relevant |
|
medical evaluation of the patient; |
|
(2) the physician has created and continues to |
|
maintain records of the patient's condition in accordance with |
|
medically accepted standards; |
|
(3) the physician has a reasonable expectation that |
|
the physician will provide follow-up care to the patient to monitor |
|
the efficacy of the use of medical cannabis as a treatment of the |
|
patient's medical condition; and |
|
(4) if the patient has given permission, the physician |
|
has notified the patient's primary care physician of the patient's |
|
medical condition and certification for the medical use of medical |
|
cannabis to treat that condition. |
|
SECTION 2.04. Section 169.002, Occupations Code, is amended |
|
to read as follows: |
|
Sec. 169.002. PHYSICIAN QUALIFIED TO RECOMMEND MEDICAL |
|
[PRESCRIBE LOW-THC] CANNABIS [TO PATIENTS WITH CERTAIN MEDICAL |
|
CONDITIONS]. (a) Only a physician qualified with respect to a |
|
patient's particular medical condition [as provided by this |
|
section] may recommend medical [prescribe low-THC] cannabis in |
|
accordance with this chapter to treat the applicable medical |
|
condition. |
|
(b) A physician is qualified to recommend medical |
|
[prescribe low-THC] cannabis with respect to a patient's particular |
|
medical condition if the physician: |
|
(1) is licensed under this subtitle; |
|
(2) has a bona fide physician-patient relationship |
|
with the patient [is board certified in a medical specialty |
|
relevant to the treatment of the patient's particular medical |
|
condition by a specialty board approved by the American Board of |
|
Medical Specialties or the Bureau of Osteopathic Specialists]; and |
|
(3) dedicates a significant portion of clinical |
|
practice to the evaluation and treatment of the patient's |
|
particular medical condition. |
|
[(c) A physician is qualified to prescribe low-THC cannabis |
|
for the treatment of a patient with a medical condition approved by |
|
rule of the executive commissioner of the Health and Human Services |
|
Commission for treatment in an approved research program conducted |
|
under Subchapter F, Chapter 487, Health and Safety Code, if the |
|
physician is: |
|
[(1) licensed under this subtitle; and |
|
[(2) certified by a compassionate-use institutional |
|
review board created under Section 487.253, Health and Safety Code, |
|
that oversees patient treatment undertaken as part of that approved |
|
research program.] |
|
SECTION 2.05. Section 169.003, Occupations Code, is amended |
|
to read as follows: |
|
Sec. 169.003. RECOMMENDATION [PRESCRIPTION] OF MEDICAL |
|
[LOW-THC] CANNABIS. A physician described by Section 169.002 may |
|
recommend medical [prescribe low-THC] cannabis to a patient if: |
|
(1) the patient is a permanent resident of the state; |
|
(2) the physician complies with the registration |
|
requirements of Section 169.004; and |
|
(3) the physician certifies to the department that: |
|
(A) there is a bona fide physician-patient |
|
relationship; |
|
(B) the patient has a diagnosis or symptoms such |
|
that, in the physician's professional judgment and review of past |
|
treatments, the patient is likely to receive therapeutic or |
|
palliative benefit from medical cannabis [is diagnosed with: |
|
[(i) epilepsy; |
|
[(ii) a seizure disorder; |
|
[(iii) multiple sclerosis; |
|
[(iv) spasticity; |
|
[(v) amyotrophic lateral sclerosis; |
|
[(vi) autism; |
|
[(vii) cancer; |
|
[(viii) an incurable neurodegenerative |
|
disease; |
|
[(ix) post-traumatic stress disorder; or |
|
[(x) a medical condition that is approved |
|
for a research program under Subchapter F, Chapter 487, Health and |
|
Safety Code, and for which the patient is receiving treatment under |
|
that program]; and |
|
(C) [(B)] the physician determines the risk of |
|
the medical use of medical [low-THC] cannabis by the patient is |
|
reasonable in light of the potential benefit for the patient. |
|
SECTION 2.06. The heading to Section 169.004, Occupations |
|
Code, is amended to read as follows: |
|
Sec. 169.004. MEDICAL [LOW-THC] CANNABIS RECOMMENDATION |
|
[PRESCRIBER] REGISTRATION. |
|
SECTION 2.07. Section 169.004(a), Occupations Code, is |
|
amended to read as follows: |
|
(a) Before a physician [qualified to prescribe low-THC |
|
cannabis under Section 169.002] may recommend [prescribe] or renew |
|
a recommendation [prescription] for medical [low-THC] cannabis for |
|
a patient under this chapter, the physician must register [as the |
|
prescriber for that patient] in the compassionate-use registry |
|
maintained by the department under Section 487.054, Health and |
|
Safety Code. The physician's registration must indicate: |
|
(1) the physician's name; and |
|
(2) for each patient: |
|
(A) the patient's name and date of birth; |
|
(B) the nature of the patient's diagnosis or |
|
symptom being treated by medical cannabis; |
|
(C) [(3)] the dosage recommended for [prescribed |
|
to] the patient; |
|
(D) [(4)] the means of administration ordered |
|
for the patient; |
|
(E) [and |
|
[(5)] the total amount of medical [low-THC] cannabis |
|
required to fill the patient's recommendation; and |
|
(F) any severe adverse events the patient may |
|
experience due to the medical use of medical cannabis |
|
[prescription]. |
|
SECTION 2.08. Section 169.005, Occupations Code, is amended |
|
to read as follows: |
|
Sec. 169.005. PATIENT TREATMENT PLAN. A physician |
|
described by Section 169.002 who recommends medical [prescribes |
|
low-THC] cannabis for a patient's medical use under this chapter |
|
must maintain a patient treatment plan that indicates: |
|
(1) the dosage, means of administration, and planned |
|
duration of treatment for the medical [low-THC] cannabis; |
|
(2) a plan for monitoring the patient's symptoms; and |
|
(3) a plan for monitoring indicators of tolerance or |
|
reaction to medical [low-THC] cannabis. |
|
SECTION 2.09. Section 169.0011, Occupations Code, is |
|
repealed. |
|
ARTICLE 3. CONFORMING AMENDMENTS |
|
SECTION 3.01. Section 161.001(c), Family Code, is amended |
|
to read as follows: |
|
(c) Evidence of one or more of the following does not |
|
constitute clear and convincing evidence sufficient for a court to |
|
make a finding under Subsection (b) and order termination of the |
|
parent-child relationship: |
|
(1) the parent homeschooled the child; |
|
(2) the parent is economically disadvantaged; |
|
(3) the parent has been charged with a nonviolent |
|
misdemeanor offense other than: |
|
(A) an offense under Title 5, Penal Code; |
|
(B) an offense under Title 6, Penal Code; or |
|
(C) an offense that involves family violence, as |
|
defined by Section 71.004 of this code; |
|
(4) the parent provided or administered medical |
|
[low-THC] cannabis to a child for whom the medical [low-THC] |
|
cannabis was recommended [prescribed] under Chapter 169, |
|
Occupations Code; |
|
(5) the parent declined immunization for the child for |
|
reasons of conscience, including a religious belief; |
|
(6) the parent sought an opinion from more than one |
|
medical provider relating to the child's medical care, transferred |
|
the child's medical care to a new medical provider, or transferred |
|
the child to another health care facility; or |
|
(7) the parent allowed the child to engage in |
|
independent activities that are appropriate and typical for the |
|
child's level of maturity, physical condition, developmental |
|
abilities, or culture. |
|
SECTION 3.02. Section 262.116(a), Family Code, is amended |
|
to read as follows: |
|
(a) The Department of Family and Protective Services may not |
|
take possession of a child under this subchapter based on evidence |
|
that the parent: |
|
(1) homeschooled the child; |
|
(2) is economically disadvantaged; |
|
(3) has been charged with a nonviolent misdemeanor |
|
offense other than: |
|
(A) an offense under Title 5, Penal Code; |
|
(B) an offense under Title 6, Penal Code; or |
|
(C) an offense that involves family violence, as |
|
defined by Section 71.004 of this code; |
|
(4) provided or administered medical [low-THC] |
|
cannabis to a child for whom the medical [low-THC] cannabis was |
|
recommended [prescribed] under Chapter 169, Occupations Code; |
|
(5) declined immunization for the child for reasons of |
|
conscience, including a religious belief; |
|
(6) sought an opinion from more than one medical |
|
provider relating to the child's medical care, transferred the |
|
child's medical care to a new medical provider, or transferred the |
|
child to another health care facility; |
|
(7) allowed the child to engage in independent |
|
activities that are appropriate and typical for the child's level |
|
of maturity, physical condition, developmental abilities, or |
|
culture; or |
|
(8) tested positive for marihuana, unless the |
|
department has evidence that the parent's use of marihuana has |
|
caused significant impairment to the child's physical or mental |
|
health or emotional development. |
|
SECTION 3.03. Section 411.0891(a), Government Code, is |
|
amended to read as follows: |
|
(a) The department may obtain as provided by Subsection |
|
(a-1) criminal history record information that relates to a person |
|
who: |
|
(1) is an applicant for or holds a registration issued |
|
by the director under Subchapter C, Chapter 481, Health and Safety |
|
Code, that authorizes the person to manufacture, distribute, |
|
analyze, or conduct research with a controlled substance; |
|
(2) is an applicant for or holds a registration issued |
|
by the department under Chapter 487, Health and Safety Code, to be a |
|
director, manager, or employee of a medical cannabis [dispensing] |
|
organization, as defined by Section 487.001, Health and Safety |
|
Code; |
|
(3) is an applicant for or holds an authorization |
|
issued by the department under Section 521.2476, Transportation |
|
Code, to do business in this state as a vendor of ignition interlock |
|
devices; |
|
(4) is an applicant for or holds certification by the |
|
department as an inspection station or an inspector under |
|
Subchapter G, Chapter 548, Transportation Code, holds an inspection |
|
station or inspector certificate issued under that subchapter, or |
|
is the owner of an inspection station operating under that chapter; |
|
(5) is an applicant for or holds a certificate of |
|
registration issued by the department under Chapter 1956, |
|
Occupations Code, to act as a metal recycling entity; |
|
(6) is an applicant for or holds a license to carry a |
|
handgun issued by the department under Subchapter H, or is an |
|
applicant for or holds a certification as an instructor issued by |
|
the department under this chapter; |
|
(7) is an applicant for or holds a Capitol access pass |
|
issued by the department under Section 411.0625; or |
|
(8) is an applicant for or holds a license or |
|
commission issued by the department under Chapter 1702, Occupations |
|
Code. |
|
SECTION 3.04. Section 443.202(a), Health and Safety Code, |
|
is amended to read as follows: |
|
(a) This section does not apply to medical [low-THC] |
|
cannabis regulated under Chapter 487. |
|
SECTION 3.05. Section 443.2025(a), Health and Safety Code, |
|
is amended to read as follows: |
|
(a) This section does not apply to medical [low-THC] |
|
cannabis regulated under Chapter 487. |
|
SECTION 3.06. Section 481.062(a), Health and Safety Code, |
|
is amended to read as follows: |
|
(a) The following persons may possess a controlled |
|
substance under this chapter without registering with the Federal |
|
Drug Enforcement Administration: |
|
(1) an agent or employee of a manufacturer, |
|
distributor, analyzer, or dispenser of the controlled substance who |
|
is registered with the Federal Drug Enforcement Administration and |
|
acting in the usual course of business or employment; |
|
(2) a common or contract carrier, a warehouseman, or |
|
an employee of a carrier or warehouseman whose possession of the |
|
controlled substance is in the usual course of business or |
|
employment; |
|
(3) an ultimate user or a person in possession of the |
|
controlled substance under a lawful order of a practitioner or in |
|
lawful possession of the controlled substance if it is listed in |
|
Schedule V; |
|
(4) an officer or employee of this state, another |
|
state, a political subdivision of this state or another state, or |
|
the United States who is lawfully engaged in the enforcement of a |
|
law relating to a controlled substance or drug or to a customs law |
|
and authorized to possess the controlled substance in the discharge |
|
of the person's official duties; |
|
(5) if the substance is tetrahydrocannabinol or one of |
|
its derivatives: |
|
(A) a Department of State Health Services |
|
official, a medical school researcher, or a research program |
|
participant possessing the substance as authorized under |
|
Subchapter G; or |
|
(B) a practitioner or an ultimate user possessing |
|
the substance as a participant in a federally approved therapeutic |
|
research program that the commissioner has reviewed and found, in |
|
writing, to contain a medically responsible research protocol; or |
|
(6) a medical cannabis [dispensing] organization |
|
licensed under Subchapter C, Chapter 487, that possesses medical |
|
[low-THC] cannabis. |
|
SECTION 3.07. Sections 481.111(e) and (f), Health and |
|
Safety Code, are amended to read as follows: |
|
(e) Sections 481.120, 481.121, 481.122, and 481.125 do not |
|
apply to a person who engages in the acquisition, possession, |
|
production, cultivation, delivery, or disposal of a raw material |
|
used in or by-product created by the production or cultivation of |
|
medical [low-THC] cannabis if the person: |
|
(1) for an offense involving possession only of |
|
marihuana or drug paraphernalia: |
|
(A) [,] is a patient for whom medical [low-THC] |
|
cannabis is recommended [prescribed] under Chapter 169, |
|
Occupations Code, or the patient's parent, legal guardian, or |
|
caregiver;[,] and |
|
(B) [the person] possesses medical [low-THC] |
|
cannabis obtained under a valid recommendation [prescription] from |
|
a medical cannabis [dispensing] organization; or |
|
(2) is a director, manager, or employee of a medical |
|
cannabis [dispensing] organization and the person, solely in |
|
performing the person's regular duties at the organization, |
|
acquires, possesses, produces, cultivates, dispenses, or disposes |
|
of: |
|
(A) in reasonable quantities, any medical |
|
[low-THC] cannabis or raw materials used in or by-products created |
|
by the production or cultivation of medical [low-THC] cannabis; or |
|
(B) any drug paraphernalia used in the |
|
acquisition, possession, production, cultivation, delivery, or |
|
disposal of medical [low-THC] cannabis. |
|
(f) For purposes of Subsection (e): |
|
(1) ["Dispensing organization" has the meaning |
|
assigned by Section 487.001. |
|
[(2)] "Medical [Low-THC] cannabis" has the meaning |
|
assigned by Section 169.001, Occupations Code. |
|
(2) "Medical cannabis organization" has the meaning |
|
assigned by Section 487.001. |
|
SECTION 3.08. Section 490.001(3), Health and Safety Code, |
|
is amended to read as follows: |
|
(3) "Investigational drug, biological product, or |
|
device" means a drug, biological product, or device that has |
|
successfully completed phase one of a clinical trial but the United |
|
States Food and Drug Administration or its international equivalent |
|
has not yet approved for general use and that remains under |
|
investigation in the clinical trial. The term does not include |
|
medical [low-THC] cannabis, as defined by Section 169.001, |
|
Occupations Code, or a product containing marihuana, as defined by |
|
Section 481.002, regardless of whether the cannabis or product |
|
successfully completed phase one of a clinical trial. |
|
SECTION 3.09. Section 551.004(a), Occupations Code, is |
|
amended to read as follows: |
|
(a) This subtitle does not apply to: |
|
(1) a practitioner licensed by the appropriate state |
|
board who supplies a patient of the practitioner with a drug in a |
|
manner authorized by state or federal law and who does not operate a |
|
pharmacy for the retailing of prescription drugs; |
|
(2) a member of the faculty of a college of pharmacy |
|
recognized by the board who is a pharmacist and who performs the |
|
pharmacist's services only for the benefit of the college; |
|
(3) a person who procures prescription drugs for |
|
lawful research, teaching, or testing and not for resale; |
|
(4) a home and community support services agency that |
|
possesses a dangerous drug as authorized by Section 142.0061, |
|
142.0062, or 142.0063, Health and Safety Code; or |
|
(5) a medical cannabis [dispensing] organization, as |
|
defined by Section 487.001, Health and Safety Code, that |
|
cultivates, processes, tests, and dispenses medical [low-THC] |
|
cannabis, as authorized by a license issued under Subchapter C, |
|
Chapter 487, Health and Safety Code, to a patient listed in the |
|
compassionate-use registry established under that chapter. |
|
ARTICLE 4. TRANSITIONS AND EFFECTIVE DATE |
|
SECTION 4.01. Not later than December 31, 2025, the public |
|
safety director of the Department of Public Safety shall adopt |
|
rules as required to implement, administer, and enforce this Act. |
|
SECTION 4.02. (a) A license to operate as a dispensing |
|
organization issued under Chapter 487, Health and Safety Code, |
|
before the effective date of this Act continues to be valid after |
|
the effective date of this Act until that license expires. |
|
(b) The registration of a director, manager, or employee of |
|
a dispensing organization under Subchapter D, Chapter 487, Health |
|
and Safety Code, continues to be valid after the effective date of |
|
this Act until that registration expires. |
|
SECTION 4.03. (a) Not later than April 1, 2026, the |
|
Department of Public Safety shall license cannabis cultivation |
|
organizations in accordance with Subchapter C, Chapter 487, Health |
|
and Safety Code, as amended by this Act, provided that the |
|
applicants for a license have met all requirements for approval |
|
under that subchapter. |
|
(b) Not later than June 1, 2026, the Department of Public |
|
Safety shall license other classes of medical cannabis |
|
organizations in accordance with Subchapter C, Chapter 487, Health |
|
and Safety Code, as amended by this Act, provided that the |
|
applicants for a license have met all requirements for approval |
|
under that subchapter. |
|
SECTION 4.04. This Act takes effect September 1, 2025. |